Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid and controlled hypotension for bleeding reduction in craniosynostosis surgery
IRCT20190328043128N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of tranexamic acid in Craniosynostosis (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Amount of bleeding, Amount of transfused blood and 2 more. Started May 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Craniosynostosis
Beyond the preview
Go deeper on IRCT20190328043128N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190328043128N1.